Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05201833 · ClinicalTrials.gov registry record

TRACK-TBI Longitudinal Biomarker Study

A clinical trial of Traumatic Brain Injury, sponsored by University of Pennsylvania.

Active
Registry status
300
Enrollment target
11
Study locations

NCT05201833: Active study of Traumatic Brain Injury, sponsored by University of Pennsylvania.

NCT05201833 is a study of Traumatic Brain Injury that is active but no longer recruiting, run by University of Pennsylvania. The registered enrollment target is 300 participants, roughly in line with the 276-participant average among 171 other Traumatic Brain Injury trials with a reported enrollment target. The trial reports 11 study locations across 8 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05201833, a study of Traumatic Brain Injury, is active but no longer recruiting, sponsored by University of Pennsylvania.

ACTIVE NOT RECRUITING
Registry status
300 participants
Enrollment target
11
Study locations

Study Summary

The overarching goal of this study is to improve understanding of the long-range natural history of TBI by extending follow-up of a previously enrolled cohort (TRACK-TBI) beyond the first 12 months after injury.

Conditions Studied

Traumatic Brain Injury

Interventions

  • PROCEDURE Blood Draw
  • BEHAVIORAL In-Person Outcome Assessment
  • PROCEDURE 3T Magnetic Resonance Imaging (MRI)
  • BEHAVIORAL Telephone Outcome Assessment

Study Locations (11)

Texas

  • University of Texas at Austin - Austin
  • University of Texas Southwestern - Dallas
  • Baylor College of Medicine - Houston

Pennsylvania

  • University of Pennsylvania/Penn Presbyterian Medical Center - Philadelphia
  • University of Pittsburgh - Pittsburgh

California

  • University of California, San Francisco - San Francisco

Massachusetts

  • Spaulding Rehabilitation Hospital - Charlestown

Ohio

  • University of Cincinnati - Cincinnati

Utah

  • University of Utah - Salt Lake City

Virginia

  • Virginia Commonwealth University - Richmond

Washington

  • University of Washington - Seattle

Trial Details

FieldValue
Enrollment Target 300 participants
Start Date 2022-03-01
Est. Completion 2027-02-28

Sponsor

University of Pennsylvania

1,423 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05201833

The ClinicalTrials.gov registry entry for NCT05201833 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 276-participant average among 171 other Traumatic Brain Injury trials with a reported enrollment target. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Traumatic Brain Injury appearing as the primary indexed condition, and to 4 interventions - of which Blood Draw is the first listed.

NCT05201833 reports 11 study locations spanning 8 distinct geographic areas - top geographies include Texas, Pennsylvania, California.

Frequently Asked Questions

What is clinical trial NCT05201833 about?

NCT05201833 is a clinical study titled "TRACK-TBI Longitudinal Biomarker Study". The overarching goal of this study is to improve understanding of the long-range natural history of TBI by extending follow-up of a previously enrolled cohort (TRACK-TBI) beyond the first 12 months after injury.

What is the current status of trial NCT05201833?

This trial is currently active not recruiting. The enrollment target is 300 participants. The study started on 2022-03-01. Estimated completion is 2027-02-28.

What conditions does trial NCT05201833 study?

This clinical trial studies the following conditions: Traumatic Brain Injury.

What interventions are being tested in trial NCT05201833?

The interventions under investigation include: Blood Draw (PROCEDURE), In-Person Outcome Assessment (BEHAVIORAL), 3T Magnetic Resonance Imaging (MRI) (PROCEDURE), Telephone Outcome Assessment (BEHAVIORAL).

Who is sponsoring clinical trial NCT05201833?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05201833 being conducted?

This trial has 11 study locations across California, Massachusetts, Ohio, Pennsylvania, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Traumatic Brain Injury

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Traumatic Brain Injury

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Related

Compare this shortlist side-by-side

Read our methodology - how this data is sourced, computed, and verified.
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.